Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-513209-30-00Phase 3Authorised
Phase 3, randomised, double-blind trial in influenza comparing Dexamethasone + oseltamivir with Placebo + oseltamivir (2 arms). Primary endpoint: Hospital Recovery Scale status at day 7. Planned start Nov 2024; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-513209-30-00.